Trial record 1 of 2 for:
TUR01
Comparative Pharmacokinetic, Safety, Tolerability and Immunogenicity Study of Adalimumab in Healthy Subjects
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. |
ClinicalTrials.gov Identifier: NCT04439929 |
Recruitment Status :
Completed
First Posted : June 19, 2020
Last Update Posted : June 19, 2020
|
Sponsor:
Turgut İlaçları A.Ş.
Information provided by (Responsible Party):
Turgut İlaçları A.Ş.
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
No Study Results Posted on ClinicalTrials.gov for this Study
Recruitment Status : | Completed |
---|---|
Actual Primary Completion Date : | January 16, 2020 |
Actual Study Completion Date : | January 16, 2020 |